Gareth Sanger
Gareth Sanger is a renowned British pharmacologist, known for his significant contributions to the field of pharmacology.
Pronunciation
Gareth Sanger is pronounced as /ˈɡærɛθ ˈseɪndʒər/.
Etymology
The name Gareth is of Welsh origin, meaning "gentle". Sanger is a surname of German origin, meaning "singer".
Career
Gareth Sanger has made significant contributions to the field of pharmacology, particularly in the area of gastroenterology. He is known for his research on 5-HT receptors, which are a group of G protein-coupled receptors and ligand-gated ion channels found in the central and peripheral nervous systems.
Contributions
One of his notable contributions is the discovery of the 5-HT4 receptor agonist, prucalopride, a drug used for the treatment of chronic constipation. He also contributed to the development of alosetron, a 5-HT3 receptor antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women.
Related Terms
- Pharmacology
- Gastroenterology
- 5-HT receptors
- G protein-coupled receptors
- Ligand-gated ion channels
- 5-HT4 receptor
- Prucalopride
- Alosetron
- Irritable bowel syndrome
External links
- Medical encyclopedia article on Gareth Sanger
- Wikipedia's article - Gareth Sanger
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski